Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer
Sponsor: Junpeng Wang
Summary
We plan to conduct a prospective, two-arm, open-label phase Ⅱ study to evaluate whether transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab significantly improves the efficacy and safety compared with systemic FOLFOX therapy plus/minus cetuximab/bevacizumab in elderly patients with advanced unresectable colorectal cancer.
Official title: CLINICAL EFFICACY OF TRANSARTERIAL CHEMOEMBOLIZATION IN ELDERLY PATIENTS WITH ADVANCED UNRESECTABLE COLORECTAL CANCER
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-10-01
Completion Date
2026-10-01
Last Updated
2025-10-07
Healthy Volunteers
No
Interventions
Transarterial chemoembolization
Transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab